Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-β

Circulation

Volumn 108, Issue 2, 2003, Pages 211-217

  Maggi, Adriana ^a,b   Cignarella, Andrea ^c   Brusadelli, Alessia ^a   Bolego, Chiara ^c   Pinna, Christian ^c   Puglisi, Lina ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Ctr of Excellence on Neurodeg Dis   (Italy)

^c NONE

Author keywords

Diabetes mellitus; Hormones; Myocytes; Nitric oxide synthase

Indexed keywords

CYTOKINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOPROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; HORMONE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; SYNTHESIS;

ANIMALS; AORTA; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG RESISTANCE; ENZYME INDUCTION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RNA, MESSENGER; STREPTOZOCIN;

EID: 0037770380     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000079311.39939.94     Document Type: Article

References (33)

1. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146.
2. De Vriese AS, Verbeuren TJ, Van de Voorde J. et al. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974.
3. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986;250: H822-H827.
4. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-267.
5. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C1437.
6. Bardell AL, MacLeod KM. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther. 2001;296:252-259.
7. Bolego C, Cignarella A, Zancan V, et al. Diabetes abolishes the vascular protective effects of estrogen in female rats. Life Sci. 1999;64:741-749.
8. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155:57-61.
9. Lindner V, Kim SK, Karas RH, et al. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res. 1998;83:224-229.
10. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89: 1943-1950.
11. Zancan V, Santagati S, Bolego C, et al. 17β-Estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells. Endocrinology. 1999;140:2004-2009.
12. Vegeto E, Pollio G, Pellicciari C, et al. Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J. 1999:13:793-803.
13. Furchgott RF. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep. 1999;19:235-251.
14. Mendelsohn ME. Nongenomic E. R-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ Res. 2000;87:956-960.
15. Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:401-406.
16. Ross R. The smooth muscle cell, II: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;103:2787-2796.
17. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
18. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 2000;14:1889-1900.
19. Tamura K, Yamaguchi K, Kogo H. 17β-Estradiol inhibits ovariectomy-induced expression of inducible nitric oxide synthase in rat aorta in vivo. Life Sci. 2000;66:259-264.
20. Noris M, Todeschini M, Zappella S, et al. 17β-Estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases. Am J Physiol Renal Physiol. 2000;279:F626-F635.
21. Saito S, Aras RS, Lou H, et al. Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells. J Heart Lung Transplant. 1999;18:937-945.
22. Kauser K, Sonnenberg D, Diel P, et al. Effect of 17β-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br J Pharmacol. 1998;123:1089-1096.
23. Cuzzocrea S, Santagati S, Sautebin L, et al. 17β-Estradiol anti-inflammatory activity in carrageenan-induced pleurisy. Endocrinology. 2000;141:1455-1463.
24. Vegeto E, Bonincontro C, Pollio G, et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci. 2001;21:1809-1818.
25. Miller L, Alley EW, Murphy WJ, et al. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol. 1996;59:442-450.
26. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
27. 2 dependent and involves two functionally separate mechanisms. Mol Endocrinol. 2001;15:1929-1940.
28. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997;277: 1508-1510.
29. Zhu Y, Bian Z, Lu P, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science. 2002;295:505-508.
30. Weatherman RV, Scanlan TS. Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. J Biol Chem. 2001;276:3827-3832.
31. Yu WJ, Juang SW, Chin WT, et al. Decrease of nitric oxide synthase in the cerebrocortex of streptozotocin-induced diabetic rats. Neurosci Lett. 1999;272:99-102.
32. Perreault M, Dombrowski L, Marette A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia. 2000;43:427-437.
33. Muniyappa R, Srinivas PR, Ram JL, et al. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension. 1998;31: 289-295.